Pharmacological blockade of Ang II formation and AT1R-mediated actions with ACE inhibitors and ARBs (Fig. 1), respectively, is commonly used for hypertension treatment in obese and type II diabetic patients due to their positive metabolic profile. Here, ACE is linked to Hypertension.